Expanding Findings for Federal Opioid Research and Treatment Act

Passed Senate with an amendment by Voice Vote. (text of amendment in the nature of a substitute: CR S7929)

Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote.

The committee substitute withdrawn by Unanimous Consent.

Measure laid before Senate by unanimous consent. (consideration: CR S7929; text: CR S7929)

Placed on Senate Legislative Calendar under General Orders. Calendar No. 510.

Committee on Commerce, Science, and Transportation. Reported by Senator Wicker with an amendment in the nature of a substitute. With written report No. 116-248.

Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment in the nature of a substitute favorably.

Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.

Motion to reconsider laid on the table Agreed to without objection.

On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H7172)

Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H7172)

DEBATE - The House proceeded with forty minutes of debate on H.R. 3153.

Considered under suspension of the rules. (consideration: CR H7172-7173)

Ms. Johnson (TX) moved to suspend the rules and pass the bill.

Placed on the Union Calendar, Calendar No. 95.

Reported by the Committee on Science, Space, and Technology. H. Rept. 116-131.

Congress.gov source codes: 5000, H12200

Committee Consideration and Mark-up Session Held.

Referred to the House Committee on Science, Space, and Technology.

Introduced in House

Congress.gov source codes: 1000, Intro-H